Citius Pharmaceuticals, Inc. (CTXR) vs Obsidian Therapeutics Inc. (OBX)

A side-by-side comparison of Citius Pharmaceuticals, Inc. and Obsidian Therapeutics Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

CTXR

Citius Pharmaceuticals, Inc.

$14M

$0.51HealthcareDelayed quote: Oct 6, 2026, 11:31 AM EDT

OBX

Obsidian Therapeutics Inc.

$15M

$13.97HealthcareDelayed quote: Oct 6, 2026, 11:31 AM EDT

Total return — CTXR vs OBX

growth of $100 · dividends reinvested · last 1y

CTXR -0.1% (-0.1%/yr)OBX -20.9% (-20.9%/yr)CTXR compounded faster over this window

CTXR OBX

Metrics side by side

Total return (annualized)

Metric	CTXR	OBX
Total return (1Y)	-61.87%	N/A
Total return CAGR (3Y)	-68.55%	N/A
Total return CAGR (5Y)	-60.04%	N/A
Total return CAGR (10Y)	-46.34%	N/A

OBX is an index fund, so valuation, profitability, and per-company growth metrics don't apply — the head-to-head here is total return (price plus reinvested dividends).

Go deeper

Full CTXR analysis Full OBX analysis Interactive comparison tool

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.